| Literature DB >> 26070155 |
Federica Solca1, Barbara Poletti1, Stefano Zago2, Chiara Crespi3, Francesca Sassone1, Annalisa Lafronza1, Anna Maria Maraschi1, Jenny Sassone1, Vincenzo Silani4, Andrea Ciammola1.
Abstract
BACKGROUND ANDEntities:
Mesh:
Year: 2015 PMID: 26070155 PMCID: PMC4466481 DOI: 10.1371/journal.pone.0126773
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Demographic, clinical and genetic data of HD patients and control subjects.
| Symptomatic HD patients (N = 24) | Control subjects (N = 24) | |
|---|---|---|
| Age (years) | 52.33 ± 13.82 (27–78) | 52.46 ± 14.02 (28–76) |
| Education (years) | 11.38 ± 3.19 (7–17) | 11.17 ± 2.87 (8–17) |
| CAG repeats number | 45.04 ± 5.23 (39–64) | --- |
| Age at onset (years) | 47.09 ± 14.49 (23–76) | --- |
| Duration of illness (years) | 5.4 ± 3.6 (1–15) | --- |
| Total Motor Score—UHDRS Part I | 40.37±18.79 (15–76) | --- |
| Maximal Chorea—UHDRS Part I | 10.04±5.09 (0–18) | --- |
Data are expressed as mean±SD (range). UHDRS Part I: Unified Huntington Disease Rating Scale Part I
Cognitive measures in HD patients and control subjects.
| HD patients | Control subjects | ρ value | |
|---|---|---|---|
|
| 81.87±55.20 | 31.54±27.22 | 0.000002 (Kruskal-Wallis) |
|
| 226±116.63 | 80.12±51.74 | 0.000003 (Kruskal-Wallis) |
|
| 154.54±83.57 | 49.58±29.98 | 0.000003 (Kruskal-Wallis) |
|
| 13.60±3.21 | 16.53±1.40 | 0.000068 (Kruskal-Wallis) |
|
| 24.07±5.36 | 30.49±2.66 | 0.000011 (Kruskal-Wallis) |
|
| 25.54±2.83 | 28.00±1.41 | 0.000332 (Kruskal-Wallis) |
|
| 29.92±11.00 | 43.00±7.86 | 0.000021 (ANOVA) |
|
| 5.76±2.85 | 8.37±2.26 | 0.000998 (ANOVA) |
|
| 29.88±3.18 | 33.29±1.08 | 0.000019 (Kruskal-Wallis) |
|
| 13.96±9.16 | 22.92±7.37 | 0.000519 (ANOVA) |
|
| 18.33±10.13 | 43.79±9.99 | 0.000001 (ANOVA) |
|
| 22.96±11.06 | 49.46±13.00 | 0.000001 (ANOVA) |
Data are expressed as mean±SD. TMT: Trail Making Test; FAB: Frontal Assessment Battery; RCPM: Raven Coloured Progressive Matrices; MMSE: Mini-Mental State Examination; Rey’s Imm: Rey's 15 Words Test Immediate Recall; Rey's Del: Rey's 15 Words Test Delayed Recall; Token Test: Token Test; Stroop Int Test (rs): Stroop Colour-Word Interference Test (raw score); Verbal Phon Flu Test: Verbal Phonemic Fluency Test; Symbol Digit: Symbol Digit Modalities Test.
Psychological measures in HD patients and control subjects.
| HD patients | Control subjects | P value | |
|---|---|---|---|
|
| 49.58±10.23 | 42.38±8.50 | 0.009 (Kruskal-Wallis) |
|
| 47.92±12.15 | 43.92±9.01 | 0.202 (ANOVA) |
|
| 21.08±6.47 | 25.21±3.61 | 0.009 (ANOVA) |
|
| 79.37±19.30 | 93.54±9.94 | 0.002 (Kruskal-Wallis) |
|
| 68.42±31.90 | 89.67±13.61 | 0.023 (Kruskal-Wallis) |
|
| 59.21±23.50 | 76.21±18.40 | 0.008 (Kruskal-Wallis) |
|
| 57.29±46.32 | 86.46±23.29 | 0.010 (Kruskal-Wallis) |
|
| 87.92±7.04 | 83.13±9.06 | 0.047 (ANOVA) |
|
| 59.63±7.72 | 52.58±7.91 | 0.003 (ANOVA) |
|
| 60.17±9.13 | 51.33±7.23 | 0.0005 (ANOVA) |
|
| 54.17±7.65 | 60.25±11.75 | 0.028 (Kruskal-Wallis) |
|
| 10.08±11.30 | 5.79±6.19 | 0.456 (Kruskal-Wallis) |
|
| 14.29±12.17 | 11.13±6.71 | 0.749 (Kruskal-Wallis) |
Data are expressed as mean±SD. STAI-Y1/Y2: State-Trait Anxiety Inventory; Rosenberg SES: Rosenberg Self-Esteem Scale; SF-36 PF: physical functioning; SF-36 RP: role limitations due to physical health; SF-36 GH: general health; SF-36 SF: social functioning; BFQ Friend Tot (rs): Big Five Questionnaire Friendliness Total raw score; BFQ Emotional Stab IC: Big Five Questionnaire Emotional Stability-Impulse Control (T Score); BFQ Lie (T): Big Five Questionnaire Lie (T Score); Rotter I-E Scale (T): Rotter Internal-External Locus of Control Scale (T score); BDI Tot: Beck Depression Inventory Total Score; DEX: Dysexecutive Questionnaire.
Numbers of spontaneous CFT generated by HD patients and control subjects.
| No of spontaneous CFT | HD patients | Control subjects |
|---|---|---|
|
| 5 (21%) | 0 |
|
| 7 (29%) | 0 |
|
| 11 (46%) | 2 (8%) |
|
| 1 (4%) | 20 (84%) |
|
| 0 | 1 (4%) |
|
| 0 | 0 |
|
| 0 | 0 |
|
| 0 | 1 (4%) |
|
| 1.5 | 3 |
Fig 1HD patients’ and control subjects’ performance on Spontaneous Counterfactual Generation Test.
The graph shows the percentage of subjects who generated a specific number of spontaneous counterfactual thoughts.
Scores obtained at CIT by HD patients and control subjects.
|
| HD patients | Control subjects |
|---|---|---|
|
| 11 (46%) | 0 |
|
| 6 (25%) | 7 (29%) |
|
| 5 (21%) | 1 (4%) |
|
| 2 (8%) | 7 (29%) |
|
| 0 | 9 (38%) |
|
| 1 | 3 |
Fig 2HD patients’ and control subjects’ performance on Counterfactual Inference Test (CIT).
The graph shows the different percentage distribution of the CIT scores among HD patients and control subjects.
Correlations between Spontaneous Counterfactual Generation Test and cognitive tests in HD patients.
| Correlation Coefficient r | ρ value | |
|---|---|---|
|
| .540 | 0.007 |
|
| -.456 | 0.025 |
|
| .430 | 0.036 |
|
| .578 | 0.003 |
|
| .548 | 0.006 |
|
| .411 | 0.045 |